CTC
OCGN icon

Central Trust Company’s Ocugen OCGN Stock Holding History

Central Trust Company’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$497 – 1484
2024
Q3 		$497 Hold
500
– – ﹤0.01% 1363
2024
Q2 		$775 Hold
500
– – ﹤0.01% 1355
2024
Q1 		$820 Hold
500
– – ﹤0.01% 1328
2023
Q4 		$288 Hold
500
– – ﹤0.01% 1361
2023
Q3 		$200 Hold
500
– – ﹤0.01% 1349
2023
Q2 		$272 Hold
500
– – ﹤0.01% 1218
2023
Q1 		$427 Hold
500
– – ﹤0.01% 1250
2022
Q4 		$650 Hold
500
– – ﹤0.01% 1220
2022
Q3 		$1K Hold
500
– – ﹤0.01% 1267
2022
Q2 		$1K Hold
500
– – ﹤0.01% 1314
2022
Q1 		$2K Hold
500
– – ﹤0.01% 1266
2021
Q4 		$2K Hold
500
– – ﹤0.01% 1218
2021
Q3 		$4K Hold
500
– – ﹤0.01% 1139
2021
Q2 		$4K Buy
500
+300
+150% +$2.53K ﹤0.01% 1107
2021
Q1 		$1K Buy
+200
New +$1.33K ﹤0.01% 1098

Other funds holding OCGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Central Trust Company's OCGN Position: Q4 2024 in Review

Central Trust Company sold out of Ocugen (OCGN) in Q4 2024, closing a stake of 500 shares — an estimated $497 sold.

Central Trust Company first reported a position in OCGN in Q1 2021 and held it in 15 quarters. The position peaked at $4K in Q3 2021. 114 funds tracked by Wall St. Rank hold OCGN as of Q4 2024.

  • Central Trust Company reported no remaining Ocugen position as of Q4 2024 after selling out during the quarter.
  • Central Trust Company sold 500 Ocugen shares in Q4 2024, an estimated $497.
  • Central Trust Company first reported a position in Ocugen in Q1 2021 and held it in 15 quarters.
  • Central Trust Company's Ocugen position peaked at $4K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Ocugen as of Q4 2024.

Based on Central Trust Company's 13F filing for Q4 2024, filed 24 Jan 2025.